AACR: HPV Genotypes May Vary By Race

Share this content:
AACR: HPV Genotype Distribution Varies With Race
AACR: HPV Genotype Distribution Varies With Race

(HealthDay News) -- Human papillomavirus (HPV) genotype distribution seems to vary with race, according to a study presented at the American Association for Cancer Research's International Conference on Frontiers in Cancer Prevention Research, held from Oct. 27 to 30 in National Harbor, Md.

Adriana C. Vidal, Ph.D., from the Duke University School of Medicine in Durham, N.C., and colleagues describe HPV genotypes in a multi-ethnic cohort of 516 women undergoing colposcopic evaluation following an abnormal liquid-based cytology screen.

The researchers found that 72% of the women were HPV-positive; 37% had no cervical intraepithelial neoplasia (CIN), and 47%, 10%, and 6%, respectively, had CIN1, CIN2, and CIN3. Among CIN1 cases, the most frequent high-risk HPV genotypes were 16, 18, 31, 45, 52, 56, 59, and 66 in white women, and 33, 35, 58, and 68 in African-American women. Among women with CIN2-3, the most common high-risk HPV genotypes were 16, 18, 33, 35, 39, and 59 in white women, and 31, 45, 51, and 66 in African-American women.

"Although our findings need to be replicated in larger cohorts of women, they suggest that the currently available HPV vaccines, which target HPV subtypes 16 and 18 in order to prevent cervical cancer and precancerous cervical abnormalities, will be less beneficial for African-American women than non-Hispanic white women," a coauthor said in a statement.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs